Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $89.4 Million - $234 Million
-1,605,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $217 Million - $293 Million
1,605,000 New
1,605,000 $239 Million
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $26.8 Million - $37.7 Million
-191,336 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $24.2 Million - $31.3 Million
191,336 New
191,336 $27.1 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track D1 Capital Partners L.P. Portfolio

Follow D1 Capital Partners L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D1 Capital Partners L.P., based on Form 13F filings with the SEC.

News

Stay updated on D1 Capital Partners L.P. with notifications on news.